Funded Tech Companies

IconOVir Bio

Operating out of San Diego, IconOVir Bio is venture-backed, with investment from GV, Wellington Partners and Polaris Partners.

Company Overview

Contact Information

Company Background Information

Overview

IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. The Company's proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O'Shea, Ph.D., of the Salk Institute.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

1/6/2021

Financing History

Management Team

Title

Name

Email & Social

Chairman

David Chang

        

Chief Executive Officer

Mark McCamish

        

Controller

Sean Algeo

        

VP - Operations

Benjamin Stone

        

VP - Product Management

Juli DeGraw

        

Company Investors

• GV
• Wellington Partners
• Polaris Partners
• Nextech Invest (Jakob Loven)
• Bellco Capital
• Logos Capital
• Vida Ventures (Helen Kim)
• Two River (Joshua Kazam)

Browse more funded tech companies:

Iconology | iContact

Share this article

About Our Venture Capital Database

Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary